IP

Intercept Pharmaceuticals

Pharmaceuticals · Morristown, New Jersey, United States · Founded 2002

About

They aim to solve medical challenges by innovating and advancing treatments for multiple liver diseases. They also deliver the first and only fda-approved fxr agonist for the second-line treatment of primary biliary cholangitis (pbc).

Company details may include data from People Data Labs, licensed CC BY 4.0.